版本:
中国

BRIEF-Reata Pharmaceuticals secures $35 mln term loan facility

April 3 Reata Pharmaceuticals Inc

* Reata Pharmaceuticals, Inc. secures $35 million term loan facility

* Reata Pharmaceuticals Inc says entered into a $35 million loan and security agreement with Oxford Finance Llc and Silicon Valley Bank

* Reata Pharma - proceeds will be utilized primarily to support multiple phase 2, 3 clinical trial programs for bardoxolone methyl and omavaloxolone Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐